BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1035 related articles for article (PubMed ID: 29073341)

  • 1. Metabolomics toward personalized medicine.
    Jacob M; Lopata AL; Dasouki M; Abdel Rahman AM
    Mass Spectrom Rev; 2019 May; 38(3):221-238. PubMed ID: 29073341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A targeted metabolomics approach for clinical diagnosis of inborn errors of metabolism.
    Jacob M; Malkawi A; Albast N; Al Bougha S; Lopata A; Dasouki M; Abdel Rahman AM
    Anal Chim Acta; 2018 Sep; 1025():141-153. PubMed ID: 29801603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics Toward Biomarker Discovery.
    Yin P; Xu G
    Methods Mol Biol; 2017; 1619():467-475. PubMed ID: 28674904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel strategies for clinical investigation and biomarker discovery: a guide to applied metabolomics.
    Carneiro G; Radcenco AL; Evaristo J; Monnerat G
    Horm Mol Biol Clin Investig; 2019 Jan; 38(3):. PubMed ID: 30653466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics.
    Zhao YY; Lin RC
    Chem Biol Interact; 2014 May; 215():7-16. PubMed ID: 24631021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics.
    Marshall DD; Powers R
    Prog Nucl Magn Reson Spectrosc; 2017 May; 100():1-16. PubMed ID: 28552170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the Human Metabolome Database in inborn errors of metabolism.
    Mandal R; Chamot D; Wishart DS
    J Inherit Metab Dis; 2018 May; 41(3):329-336. PubMed ID: 29663269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients.
    Coene KLM; Kluijtmans LAJ; van der Heeft E; Engelke UFH; de Boer S; Hoegen B; Kwast HJT; van de Vorst M; Huigen MCDG; Keularts IMLW; Schreuder MF; van Karnebeek CDM; Wortmann SB; de Vries MC; Janssen MCH; Gilissen C; Engel J; Wevers RA
    J Inherit Metab Dis; 2018 May; 41(3):337-353. PubMed ID: 29453510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic signature of brain cancer.
    Pandey R; Caflisch L; Lodi A; Brenner AJ; Tiziani S
    Mol Carcinog; 2017 Nov; 56(11):2355-2371. PubMed ID: 28618012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key elements of metabolomics in the study of biomarkers of diabetes.
    Adamski J
    Diabetologia; 2016 Dec; 59(12):2497-2502. PubMed ID: 27714446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics.
    Yu M; Sun S; Yu J; Du F; Zhang S; Yang W; Xiao J; Xie B
    J Proteome Res; 2018 Oct; 17(10):3517-3525. PubMed ID: 30207476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Metabolomics.
    Marciano DP; Snyder MP
    Methods Mol Biol; 2019; 1978():447-456. PubMed ID: 31119679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovation in metabolomics to improve personalized healthcare.
    Cacciatore S; Loda M
    Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR and MS Methods for Metabolomics.
    Amberg A; Riefke B; Schlotterbeck G; Ross A; Senn H; Dieterle F; Keck M
    Methods Mol Biol; 2017; 1641():229-258. PubMed ID: 28748468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical pitfalls and challenges in clinical metabolomics.
    Kohler I; Verhoeven A; Derks RJ; Giera M
    Bioanalysis; 2016 Jul; 8(14):1509-32. PubMed ID: 27323646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
    Liang Q; Wang C; Li B
    Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics and health: from nutritional crops and plant-based pharmaceuticals to profiling of human biofluids.
    Marchev AS; Vasileva LV; Amirova KM; Savova MS; Balcheva-Sivenova ZP; Georgiev MI
    Cell Mol Life Sci; 2021 Oct; 78(19-20):6487-6503. PubMed ID: 34410445
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 52.